Clinical trial
Prospective Study for the Evaluation of Dengue Prognostic Biomarkers in Singapore
NCT04048837 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Study for the Evaluation of Dengue Prognostic Biomarkers in Singapore
- Lead sponsor
- National University Hospital, Singapore
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 30, 2018
- Completion date
- July 1, 2019
- Enrollment
- 200 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
dengue hemorrhagic fever, dengue shock syndrome, severe dengue